A combination of sorafenib and nilotinib reduces the growth of castrate-resistant prostate cancer
Sébastien Taurin(Arabian Gulf University), Khaled Greish(Arabian Gulf University)
Cited by 20
Related Papers
Exploiting the enhanced permeability and retention effect for tumor targeting
|Drug Discovery Today|2006|1.8k
Phosphorylation of β-Catenin by Cyclic AMP-dependent Protein Kinase
|Journal of Biological Chemistry|2006|458
Macromolecular Therapeutics
|Clinical Pharmacokinetics|2003|279
A combination of tyrosine kinase inhibitors, crizotinib and dasatinib for the treatment of glioblastoma multiforme
|Oncotarget|2015|32
A novel curcumin derivative increases the cytotoxicity of raloxifene in estrogen receptor-negative breast cancer cell lines
|International Journal of Oncology|2015|13